AUCTORES
Globalize your Research
Letter to Editor | DOI: https://doi.org/10.31579/2641-0419/443
Section for Neuroelectronic Systems, Clinic for Neurosurgery, University of Freiburg, Germany.
*Corresponding Author: Thomas J. Feuerstein, Section for Neuroelectronic Systems, Clinic for Neurosurgery, University of Freiburg, Germany.
Citation: Thomas J. Feuerstein, (2024), How and when do β-Adrenoceptor Ligands Enhance Inotropy in Acute Heart Failure? J Clinical Cardiology and Cardiovascular Interventions, 7(13); DOI: 10.31579/2641-0419/443
Copyright: © 2024, Thomas J. Feuerstein. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 13 November 2024 | Accepted: 20 November 2024 | Published: 27 November 2024
Keywords: coronary heart disease; acute myocardial infarction; heart transplant rejection; therapeutic plasma exchange; immunoadsorption
.
In a recent paper, we highlighted that the super-selective, short-acting β1-adrenoceptor antagonist Landiolol (Feuerstein and Krumpl 2022, [1]), which is administered to patients experiencing acute left ventricular decompensation, did not worsen but, in fact, improved the cardiovascular status of these patients. The mechanisms previously proposed to explain the beneficial effects of β-blockers, such as Landiolol, in acute heart failure (AHF) are detailed in [1]. For example, β-blockers may mitigate the negative impacts of endogenous catecholamines, including tachycardia and tachyarrhythmias.
However, the mechanism we proposed for the beneficial effects of β1-blockers in acute AHF, particularly Landiolol, significantly diverges from conventional explanations. In the context of AHF, where there are highly elevated levels of endogenous agonists—noradrenaline and adrenaline—, their binding to β1-adrenoceptor dimers does not produce the expected negative inotropic effects typically associated with β-blockers. On the contrary, negative inotropy is transformed into positive inotropy at moderate to low concentrations of a β1-adrenoceptor antagonist. This conversion occurs only when negative cooperativity is a dominant factor (see, for example, [2]).
Negative cooperativity, an important phenomenon observed in β1-adrenergic receptors in the heart, influences how dimeric receptors respond to their agonists. This phenomenon has significant implications for understanding cardiac function and drug interactions. Negative cooperativity in β1-adrenergic receptors refers to a decrease in the binding affinity of a subsequent agonist after the initial binding of a first agonist to one receptor in a dimer. This effect arises from allosteric interactions between the two receptor protomers of this dimer.
We discovered that in AHF, the negative cooperativity of the β1-receptor dimers was reduced by the β1-blocker Landiolol, leading to its unexpected positive inotropic effect [1]. To better understand this observation, we developed receptor binding model calculations based on the binomial distribution, which shed light on the intriguing phenomenon where β1-blockers, typically associated with negative inotropic effects, can instead induce positive inotropy. Note that, in the failing heart, the proportion of β1 and β2 receptors reaches a balanced 50/50 ratio (see [1] for citations). However, the shift from negative to positive inotropy is attributed exclusively to β1-adrenoceptor antagonism (see below).
When publishing the aforementioned paper [1], we were mindful of the need to address any reservations regarding the use of Landiolol to treat AHF. Our approach, which utilized a discrete probability distribution to describe the interactions between the two identical protomers of the β1-adrenoceptor dimers, was not easily comprehensible. However, we believed that understanding this rather unconventional approach was essential for cardiologists treating AHF with β-blockers.
The following issue arose: As is common in AHF, a putative β-adrenergic stimulant such as dobutamine is often co-administered in these patients, alongside Landiolol in our case. We justified the additional use of dobutamine as standard practice, assuming it acted as a pure, low-affinity agonist at the protomers of the β1-dimers (see [1]). This perspective suggested that dobutamine would contribute minimally to the agonist occupation of the β1-adrenoceptor dimers, given the significantly higher affinity of the endogenous catecholamines.
So far, textbook knowledge categorizes the racemic mixture of dobutamine as a β-adrenoceptor agonist. It is understood that the (+)-enantiomer activates both β1- and β2-receptors, whereas the (–)-enantiomer is responsible for agonism at the α1 receptor. Consequently, the effects at α1 and β2 receptors counterbalance each other, leading to what appears to be selective β1-agonism.
In addition, one of the reasons why the co-administration of Landiolol and dobutamine may be advantageous lies in the ability of a selective β1-receptor blocker to effectively antagonize the agonistic effects of dobutamine on the β1-receptors in the sinus node, as well as its positive inotropic effects via the β1-receptors in the myocardium. However, it does not inhibit dobutamine's positive inotropic effects mediated through the upregulated myocardial β2-receptors or its activation of α1 receptors.
It is important to note that the combination of selective β1-receptor ligands, such as Landiolol, with inotropes that act downstream of the β-receptors, such as milrinone [3] or levosimendan [e.g. 4, 5], also constitutes a logical approach.
However, research has effectively shown dobutamine to be a partial agonist, shedding light on the complex interactions between agonists and antagonists at the β1-adrenoceptors: In 2011, a comprehensive preclinical study elucidated the structural basis for both agonist and partial agonist actions on β1-receptors, classifying dobutamine as partial β1-receptor agonist [6]. Generally, noteworthy differences have been described in the β1-catecholamine binding pocket when full agonists are bound compared to when an antagonist or partial antagonist is bound.
Moreover, an earlier significant paper, published in 1998, explored the (ant)agonism of dobutamine at β-adrenoceptors, successfully integrating both preclinical and clinical perspectives [7]. Preclinically, dobutamine activated β2-adrenoceptors as partial agonist compared to the full agonist adrenaline. Clinically, dobutamine's partial agonism and adrenaline's full agonism may have targeted both β1- and β2-adrenoceptors in the patients investigated following aortocoronary bypass surgery [7]. Regarding the previously mentioned negative cooperativity, it should not be assumed that dimeric β2-receptors play a role in this phenomenon. Recent studies have demonstrated that the only confirmed function of dimeric β2-receptors is their constitutive activity, supported by molecular insights into this activity in living cells [8].
β1-Receptors most probably represented the majority of heart β-receptors in the patients without heart failure [7].
Regarding the three ligands (an endogenous catecholamine, dobutamine, and Landiolol) present at the β-adrenoceptors in AHF, as described in [1], the agonist component of dobutamine, which has low affinity, cannot influence the effects of the highly elevated, high-affinity endogenous agonists. These endogenous agonists occupy nearly all protomers of the existing dimers, resulting in negative cooperativity among the dimers.
In the absence of β-antagonists such as Landiolol, the β1-antagonistic component of dobutamine has the potential to protect one protomer of a dimer with two agonistically occupied protomers from being further occupied by an endogenous agonist. This allows dobutamine to counteract the negative cooperativity of this dimer, thereby producing a positive inotropic effect. It is implausible to attribute this positive inotropy solely to dobutamine's low-affinity β-agonism, since high-affinity endogenous catecholamines almost fully occupy the β-receptors in acute AHF.
However, in the presence of the high-affinity β1-blocker Landiolol, this inotropic enhancement due to dobutamine’s antagonistic effect may be diminished.
We intentionally chose not to address the partial (ant)agonism of dobutamine at β-adrenoceptors, as our goal was to streamline our message in [1] and avoid overwhelming the reader with complexities regarding dobutamine's pharmacological profile. We aimed to enhance the comprehensibility and acceptance of our paper by keeping [1] straightforward, refraining from overcrowding it with additional information about dobutamine not being a pure β-agonist.
Nevertheless, randomized double-blind clinical studies have convincingly demonstrated dobutamine's partial (ant)agonist action. This is evidenced by the attenuation of dobutamine's effects in the presence of β-blockers observed in the LIDO study [4, 5]. This finding was further supported by a subpopulation analysis of the SURVIVE trial [9], which highlighted a reduced inotropic effect of dobutamine when co-administered with β-blockers. In this analysis, β-blockers were more frequently used (88% of the subpopulation in Finland) compared to other countries (52% of the rest of the SURVIVE trial).
In summary, the clinical studies detailing the interactions between dobutamine and genuine β-blockers in AHF suggest that the presence of β-blockers diminishes dobutamine's positive inotropic effects. Only in its role as a β-adrenoceptor antagonist can dobutamine lose its positive inotropic effect in the presence of other pure β-antagonists.
With regard to Landiolol and other selective, short-acting β1-adrenoceptor antagonists for use in AHF, it seems essential to further elucidate the interaction between pure β1-adrenoceptor antagonists and dobutamine. I propose conducting a well-powered comparative clinical study to determine whether dobutamine affects the anticipated positive inotropic effects of pure β1-adrenoceptor antagonists in AHF patients. Such a study could provide a definitive answer on whether, in the presence of high endogenous catecholamine concentrations, dobutamine reduces, has no effect on, or even enhances the positive inotropic effects of these antagonists.
In this study, all AHF patients would receive an intriguing β1-adrenoceptor antagonist, such as Landiolol, with half of these patients also receiving dobutamine. If the dobutamine-treated patients show lower or unchanged inotropic effects in the presence of the pure β1-receptor antagonist, future use of dobutamine alongside a true β1-antagonist could be reconsidered. Conversely, if a beneficial effect of dobutamine is observed, further investigation would be required to understand this effect, particularly given dobutamine's low affinity for β-adrenoceptors [4, 9]. Any previously unrecognized properties of dobutamine should be thoroughly explored.
If confirmed, this proposed study could prompt a reevaluation of the combined use of dobutamine and selective β1-receptor antagonists in clinical practice for AHF treatment.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
My Testimonial Covering as fellowing: Lin-Show Chin. The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews.
My experience publishing in Psychology and Mental Health Care was exceptional. The peer review process was rigorous and constructive, with reviewers providing valuable insights that helped enhance the quality of our work. The editorial team was highly supportive and responsive, making the submission process smooth and efficient. The journal's commitment to high standards and academic rigor makes it a respected platform for quality research. I am grateful for the opportunity to publish in such a reputable journal.
My experience publishing in International Journal of Clinical Case Reports and Reviews was exceptional. I Come forth to Provide a Testimonial Covering the Peer Review Process and the editorial office for the Professional and Impartial Evaluation of the Manuscript.
